• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酯化脂肪酸对胰岛素清除的调节作用。

Regulation of Insulin Clearance by Non-Esterified Fatty Acids.

作者信息

Najjar Sonia M, Abdolahipour Raziyeh, Ghadieh Hilda E, Jahromi Marziyeh Salehi, Najjar John A, Abuamreh Basil A M, Zaidi Sobia, Kumarasamy Sivarajan, Muturi Harrison T

机构信息

Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.

Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.

出版信息

Biomedicines. 2022 Aug 5;10(8):1899. doi: 10.3390/biomedicines10081899.

DOI:10.3390/biomedicines10081899
PMID:36009446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405499/
Abstract

Insulin stores lipid in adipocytes and prevents lipolysis and the release of non-esterified fatty acids (NEFA). Excessive release of NEFA during sustained energy supply and increase in abdominal adiposity trigger systemic insulin resistance, including in the liver, a major site of insulin clearance. This causes a reduction in insulin clearance as a compensatory mechanism to insulin resistance in obesity. On the other hand, reduced insulin clearance in the liver can cause chronic hyperinsulinemia, followed by downregulation of insulin receptor and insulin resistance. Delineating the cause-effect relationship between reduced insulin clearance and insulin resistance has been complicated by the fact that insulin action and clearance are mechanistically linked to insulin binding to its receptors. This review discusses how NEFA mobilization contributes to the reciprocal relationship between insulin resistance and reduced hepatic insulin clearance, and how this may be implicated in the pathogenesis of non-alcoholic fatty liver disease.

摘要

胰岛素将脂质储存于脂肪细胞中,并阻止脂肪分解以及非酯化脂肪酸(NEFA)的释放。在持续能量供应期间NEFA的过度释放以及腹部肥胖的增加会引发全身性胰岛素抵抗,包括在肝脏这一胰岛素清除的主要部位。这会导致胰岛素清除减少,作为肥胖中胰岛素抵抗的一种代偿机制。另一方面,肝脏中胰岛素清除的减少会导致慢性高胰岛素血症,随后胰岛素受体下调以及胰岛素抵抗。由于胰岛素作用和清除在机制上与胰岛素与其受体的结合相关联,因此明确胰岛素清除减少与胰岛素抵抗之间的因果关系变得复杂。本综述讨论了NEFA动员如何促成胰岛素抵抗与肝脏胰岛素清除减少之间的相互关系,以及这可能如何与非酒精性脂肪性肝病的发病机制相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/60c99bd0b80b/biomedicines-10-01899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/0f71c8c0c4e1/biomedicines-10-01899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/232648c182d9/biomedicines-10-01899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/46dd64872132/biomedicines-10-01899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/60c99bd0b80b/biomedicines-10-01899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/0f71c8c0c4e1/biomedicines-10-01899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/232648c182d9/biomedicines-10-01899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/46dd64872132/biomedicines-10-01899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b9/9405499/60c99bd0b80b/biomedicines-10-01899-g004.jpg

相似文献

1
Regulation of Insulin Clearance by Non-Esterified Fatty Acids.非酯化脂肪酸对胰岛素清除的调节作用。
Biomedicines. 2022 Aug 5;10(8):1899. doi: 10.3390/biomedicines10081899.
2
Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?非酯化脂肪酸与肝脏:胰岛素为何分泌至门静脉?
Diabetologia. 2000 Jul;43(7):946-52. doi: 10.1007/s001250051474.
3
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.非酒精性脂肪性肝病期间肝脏从头脂肪生成及血浆非酯化脂肪酸再酯化对血浆甘油三酯合成的贡献
Diabetes Metab. 2003 Nov;29(5):478-85. doi: 10.1016/s1262-3636(07)70061-7.
4
Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver Disease.肝脏CEACAM1的缺失:连接胰岛素抵抗与肥胖及非酒精性脂肪性肝病的统一机制。
Front Endocrinol (Lausanne). 2017 Jan 26;8:8. doi: 10.3389/fendo.2017.00008. eCollection 2017.
5
Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.肝特异性特异性细胞黏附分子 1 缺失的雄性小鼠中高胰岛素血症导致肝胰岛素抵抗,与脂肪分解无关。
Metabolism. 2019 Apr;93:33-43. doi: 10.1016/j.metabol.2019.01.008. Epub 2019 Jan 19.
6
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.罗格列酮预防大鼠脂肪酸诱导的胰岛素抵抗机制中脂质隔离的直接证明:与二甲双胍的比较。
Diabetologia. 2004 Jul;47(7):1306-1313. doi: 10.1007/s00125-004-1436-1. Epub 2004 Jul 1.
7
Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content.非酒精性脂肪性肝病患者肝脏胰岛素摄取与胰岛素抵抗相关,而与肝内脂肪含量无关。
J Clin Endocrinol Metab. 2019 May 1;104(5):1855-1865. doi: 10.1210/jc.2018-01808.
8
Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.胰岛素对人脂肪细胞非酯化脂肪酸释放的抑制作用的区域差异:与胰岛素受体磷酸化及通过胰岛素受体底物-1途径的细胞内信号传导的关系。
Diabetologia. 1998 Nov;41(11):1343-54. doi: 10.1007/s001250051075.
9
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪组织胰岛素抵抗与肝巨噬细胞的串扰。
J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10.
10
Lipid metabolism and insulin resistance in cirrhosis.肝硬化中的脂质代谢与胰岛素抵抗
J Hepatol. 1994 Jun;20(6):782-91. doi: 10.1016/s0168-8278(05)80150-3.

引用本文的文献

1
Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1.CEACAM1对胰岛素作用和肝纤维化的细胞特异性调节。
Metab Target Organ Damage. 2024 Dec;4(4). doi: 10.20517/mtod.2024.48. Epub 2024 Sep 26.
2
Involvement of a battery of investigated genes in lipid droplet pathophysiology and associated comorbidities.涉及一组研究基因在脂滴病理生理学及其相关合并症中的作用。
Adipocyte. 2024 Dec;13(1):2403380. doi: 10.1080/21623945.2024.2403380. Epub 2024 Sep 27.
3
Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus.

本文引用的文献

1
A comprehensive review on high -fat diet-induced diabetes mellitus: an epigenetic view.高脂肪饮食诱导的糖尿病:表观遗传学观点的综合评述。
J Nutr Biochem. 2022 Sep;107:109037. doi: 10.1016/j.jnutbio.2022.109037. Epub 2022 May 6.
2
The Physiology of Insulin Clearance.胰岛素清除的生理学。
Int J Mol Sci. 2022 Feb 5;23(3):1826. doi: 10.3390/ijms23031826.
3
Insulin Clearance in Obesity and Type 2 Diabetes.肥胖与 2 型糖尿病患者的胰岛素清除率。
南亚和北欧女性妊娠糖尿病后脂肪组织胰岛素抵抗情况
Metabolites. 2024 May 18;14(5):288. doi: 10.3390/metabo14050288.
4
The Health Effects of Low Glycemic Index and Low Glycemic Load Interventions on Prediabetes and Type 2 Diabetes Mellitus: A Literature Review of RCTs.低血糖指数和低血糖负荷干预对糖尿病前期和 2 型糖尿病的健康影响:RCTs 的文献综述。
Nutrients. 2023 Dec 10;15(24):5060. doi: 10.3390/nu15245060.
5
Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation.膳食相关肝炎症中天然化合物的抗血管生成作用。
Nutrients. 2023 Jun 14;15(12):2748. doi: 10.3390/nu15122748.
6
Hepatic insulin receptor: new views on the mechanisms of liver disease.肝脏胰岛素受体:肝脏疾病发病机制的新视角。
Metabolism. 2023 Aug;145:155607. doi: 10.1016/j.metabol.2023.155607. Epub 2023 Jun 2.
7
Molecular Mechanisms of Obesity-Induced Development of Insulin Resistance and Promotion of Amyloid-β Accumulation: Dietary Therapy Using Weak Organic Acids via Improvement of Lowered Interstitial Fluid pH.肥胖诱导胰岛素抵抗发展和促进淀粉样β 聚集的分子机制:通过改善降低的细胞间隙 pH 值利用弱有机酸进行饮食治疗。
Biomolecules. 2023 Apr 30;13(5):779. doi: 10.3390/biom13050779.
Int J Mol Sci. 2022 Jan 6;23(2):596. doi: 10.3390/ijms23020596.
4
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的代谢原因及后果
Metabol Open. 2021 Nov 16;12:100149. doi: 10.1016/j.metop.2021.100149. eCollection 2021 Dec.
5
Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis.脂肪组织胰岛素抵抗和脂质组改变作为非酒精性脂肪性肝炎的特征因素。
Eur J Clin Invest. 2022 Mar;52(3):e13695. doi: 10.1111/eci.13695. Epub 2021 Dec 7.
6
Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1.内皮细胞缺失癌胚抗原细胞黏附分子 1 的小鼠仍保持胰岛素敏感性。
Cells. 2021 Aug 14;10(8):2093. doi: 10.3390/cells10082093.
7
Sleeve Gastrectomy Suppresses Hepatic Glucose Production and Increases Hepatic Insulin Clearance Independent of Weight Loss.袖状胃切除术抑制肝葡萄糖生成并增加肝胰岛素清除率,而不依赖于体重减轻。
Diabetes. 2021 Oct;70(10):2289-2298. doi: 10.2337/db21-0251. Epub 2021 Aug 2.
8
Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.癌胚抗原相关细胞黏附分子 1 对肝纤维化的调控。
Metabolism. 2021 Aug;121:154801. doi: 10.1016/j.metabol.2021.154801. Epub 2021 May 28.
9
Insulin action in adipocytes, adipose remodeling, and systemic effects.胰岛素在脂肪细胞中的作用、脂肪组织重塑和全身效应。
Cell Metab. 2021 Apr 6;33(4):748-757. doi: 10.1016/j.cmet.2021.03.019.
10
Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits.胰岛素降解酶导致餐后胰岛素清除控制丧失驱动代谢异常特征。
Metabolism. 2021 May;118:154735. doi: 10.1016/j.metabol.2021.154735. Epub 2021 Feb 23.